A5004320719- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Pulmonary Hypertension Research and Treatments
- Systemic Sclerosis and Related Diseases
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Antimicrobial Resistance in Staphylococcus
- Vascular Procedures and Complications
- Aortic Disease and Treatment Approaches
- Coronary Interventions and Diagnostics
- Transplantation: Methods and Outcomes
- Cardiovascular and Diving-Related Complications
- Central Venous Catheters and Hemodialysis
- Medical Imaging and Pathology Studies
- Aortic Thrombus and Embolism
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Clinique Pasteur
2021
Hôpital Rangueil
2017-2020
Université de Toulouse
2019
Inserm
2019
Université Toulouse III - Paul Sabatier
2019
LVOT-obstruction after transcatheter mitral valve replacement (TMVR) is associated with high procedural mortality. A small estimated neo-LVOT area by computed tomography (CT) significantly LVOT obstruction, previously reported excellent correlation between predicted and actual neo-lvot on post CT.1
We aimed to compare the long-term outcomes of transaortic (TAo-AVR) and transfemoral (TF-AVR) transcatheter aortic valve replacement.Between January 2012 December 2015, consecutive TAo-AVR TF-AVR cases were compared using a propensity score-matching analysis. Primary endpoints 30-day one-year mortality; 644 TAVR patients included (163 481 TF-AVR). Peripheral artery disease (31.9% vs. 5%, p<0.001) coronary (50.0% 39.3%, p=0.009) more frequent in patients. The Society Thoracic Surgeons scores...
Abstract Objectives To evaluate the effectiveness of anticoagulant therapies in patients with clinical transcatheter heart valve (THV) thrombosis, to describe complications, and assess their risk profile was objectives. Background Little research has been conducted on THV thrombosis. Methods Patients thrombosis were identified based greater than 50% increased transvalvular gradient transthoracic echocardiogram confirmed by 4‐dimensional computed tomography, transesophageal echocardiogram, or...
<h3>Background</h3> One of the major causes systemic sclerosis (SSc)-related death is pulmonary arterial hypertension, which develops in 12–15% patients with SSc and accounts for 30–40% deaths. Consequently, monitoring pressure (PAP) resistances essential SSc. Abbas formula performed by transthoracic echocardiography (TTE) was reported as a good tool to quantify vascular (PVR). <h3>Objectives</h3> Explore accuracy TTE PVR <h3>Methods</h3> All consecutive SSc, diagnosed according 2013...
Objective. To explore the accuracy of tricuspid regurgitation velocity (TRV) to right ventricular outflow tract time-velocity integral (TVI RVOT ) ratio by Doppler determine pulmonary vascular resistance (PVR) in patients with systemic sclerosis (SSc). Methods. Thirty-five consecutive adult SSc, fulfilling 2013 European League Against Rheumatism/American College Rheumatology classification criteria, sinus rhythm referred for heart catheterization (RHC), were retrospectively included. All...
Abstract The aim of this study was to determine whether CS, measured on the preoperative contrast enhanced multislice computed tomography (MSCT), is associated with Device Success (DS), Major Adverse Cardiac Events (MACE) and paravalvular leaks (PVL) after TAVR. Methods We included 352 consecutive patients who underwent TAVR a standardized MSCT. Valvular calcifications detection defined by adding +100 Hounsfield Unit (HU) mean HU determined Region Of Interest placed in ascending aorta. CS...